May 31, 2016
For those willing to invest in the right capabilities, offering patient services can give pharma companies a tremendous opportunity.
May 20, 2016
Pharmaceutical Executive
Pharm Exec’s 10th annual Brand of the Year has raced into the lead position in the treatment-shifting immuno-oncology space.
May 17, 2016
GDP is seeing ‘track and trace’ becoming indispensable for drug product integrity. Interactive Response Technologies may offer a potential solution.
May 16, 2016
Payers, providers, patients and pharma companies all want to understand the value of specific treatments – and patient registries can help them do that.
May 02, 2016
As companies look to raise capital, selling and then leasing back real estate is a tempting option and one that other industries are utilizing, writes Karen Williamson.
Apr 26, 2016
The liver disease NASH has become a priority for the healthcare industry – and, potentially, a multi-billion-dollar market.
Apr 15, 2016
Pharmaceutical Executive
Pharm Exec profiles Roche’s Jennifer Cook, this year’s winner of the Healthcare Businesswomen’s Association (HBA) Woman of the Year award.
Apr 12, 2016
Pharmaceutical Executive
The importance of betting on outcomes, not simply risk sharing, when implementing pharma-payer arrangements.
Apr 06, 2016
William Looney speaks with DIA's Global Chief Executive to see how the organization is repositioning itself.
Apr 04, 2016
Despite all the research as to the safety and benefits of immunization, the anti-vaccine film "Vaxxed: From Cover-Up to Catastrophe” could convince millions that vaccines are unsafe, writes Jill Wechsler.
lorem ipsum